BFC Planning’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History
Bought
Maintained
Sold
Other funds holding CANF
SM
BFC Planning's CANF Position: Q3 2026 in Review
BFC Planning held its Can-Fite BioPharma American Depositary Shares (CANF) position steady in Q3 2026 at 250 shares worth $550. The position accounts for ﹤0.01% of the portfolio, ranked #3279.
BFC Planning first reported a position in CANF in Q3 2024 and has held it in 8 quarters since. The position peaked at $4.06K in Q4 2024. 11 funds tracked by Wall St. Rank hold CANF as of Q3 2026.
- BFC Planning held 250 shares of Can-Fite BioPharma American Depositary Shares worth $550 as of Q3 2026.
- BFC Planning left its Can-Fite BioPharma American Depositary Shares share count unchanged in Q3 2026.
- Can-Fite BioPharma American Depositary Shares made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3279 holding.
- BFC Planning first reported a position in Can-Fite BioPharma American Depositary Shares in Q3 2024 and has held it in 8 quarters since.
- BFC Planning's Can-Fite BioPharma American Depositary Shares position peaked at $4.06K in Q4 2024.
- 11 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.